Analysis Finds Both Under- and Overrepresentation of Demographic Groups in U.S. COVID Trials

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Analysis Finds Both Under- and Overrepresentation of Demographic Groups in U.S. COVID Trials

J.W. Schomisch

December 13, 2022 at 03:26 PM EST

A systematic review and meta-analysis of 122 U.S.-based COVID-19 clinical trials with more than 175,000 subjects found that females were underrepresented in treatment trials, while Hispanic or Latinos were overrepresented. In addition, Asian and Black subjects were underrepresented in prevention trials. “These findings show systemwide differences in representation for several... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Analysis Finds Both Under- and Overrepresentation of Demographic Groups in U.S. COVID Trials

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT